Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
April 4, 2008
Dr. Thomas Kodadek, chief of translational research, led researchers who have developed a simple and inexpensive method to screen small synthetic molecules and pull out a handful that might treat cancer and other diseases. Credit: UT Southwestern Medical Center
Researchers at UT Southwestern Medical Center have developed a simple and inexpensive method to screen small synthetic molecules and pull out a handful that might treat cancer and other diseases less expensively than current methods.
In one screen of more than 300,000 such molecules, called peptoids, the new technique quickly singled out five promising candidates that mimicked an antibody already on the market for treating cancer. One of the compounds blocked the growth of human tumors in a mouse model.
Antibodies are molecules produced by the body to help ward off infection. Natural and manmade antibodies work by latching onto very specific targets such as receptors on the surface of cells.
“Many new drugs being made today are antibodies, but they are extremely expensive to make. Financially, the U.S. health care system is going to have a difficult time accommodating the next 500 drugs being antibodies,” said Dr. Thomas Kodadek, chief of translational research at UT Southwestern and senior author of the study, which appears online and in an upcoming issue of the Journal of the American Chemical Society.
“Our results show that a peptoid can attack a harmful receptor in the body with the same precision as an antibody, but would cost much less to develop,” said Dr. Kodadek.
Peptoids are designed in the laboratory to resemble chains of natural molecules called peptides. Some peptides are used as medications, such as insulin or antibodies used to treat some cancers, but because the stomach digests them, most can’t be taken by mouth and must be injected.
By contrast, peptoids are resistant to the stomach enzymes that degrade natural peptides, so it is possible that they could be swallowed as a pill. Peptoids are much less expensive and easier to manufacture than antibodies, Dr. Kodadek said. They are also much smaller than antibodies, so they might be better at penetrating tumors or other disease sites, he said.
“Our technique is simple and fast, works with existing chemicals and needs no high-tech instrumentation, except for a microscope to detect the fluorescent colors we use to sort the compounds,” said Dr. D. Gomika Udugamasooriya, postdoctoral researcher in internal medicine and lead author of the study.
The new technique also has major advantages over traditional screening techniques that are commonly used to discover biologically active compounds from large collections. These screens, which require extensive automation, generally cost $40,000 or more; the new method can be conducted for less than $1,000.
The researchers screened about 300,000 peptoids to see which ones would interact with VEGFR2, a type of molecule on the surface of human cells. VEGFR2 is essential in creating new blood vessels through interaction with the hormone VEGF, which is normally a helpful process but is harmful to the body when the new blood vessels are nourishing a growing tumor.
A commercially produced antibody is used to treat some cancers by blocking the VEGF-VEGFR2 interaction and thus starving the tumor, but it costs a patient about $20,000 a year, Dr. Kodadek said.
The new screening technology involves hundreds of thousands of peptoids, bound to tiny plastic beads. In the study, the cells with VEGFR2 were labeled to fluoresce red and those lacking VEGFR2 were labeled to fluoresce green. After exposing the beads to the mixture of cells, the beads were examined under a fluorescent microscope. Those bound to red cells – the ones with VEGFR2 – were collected.
This screen, which took a couple of days, isolated five peptoids out of approximately 300,000 screened, showing that the process was an effective way to quickly narrow down a search, Dr. Kodadek said.
The researchers further tested one of the five peptoids that bound most tightly to VEGFR2 and found that it blocked VEGFR2’s action in cultured cells. When they gave it in low doses to mice with implanted human bone- and soft-tissue cancer, the peptoid slowed the growth of the tumors and reduced the density of blood vessels leading to them.
“This new technique of rapidly isolating biologically active peptoids offers a way to hasten the drug-discovery process and may ultimately benefit patients by providing them with new therapies at a fraction of the cost of current drugs,” Dr. Kodadek said.
Source: UT Southwestern Medical Center
-
Preliminary new blood test to detect Alzheimer's disease uncovered
Feb 11, 2011 |
4.9 / 5 (9) |
0
-
A blood test for Alzheimer's disease?
Jan 06, 2011 |
4.5 / 5 (2) |
0
-
Light activated 'warhead' turns modest molecules into super protein killers
Mar 14, 2010 |
5 / 5 (2) |
1
-
Study describes new tool in the fight against autoimmune diseases, blood cancers
Nov 30, 2009 |
4 / 5 (2) |
0
-
Shaken, not stirred: Scientists spy molecular maneuvers
Oct 18, 2011 |
5 / 5 (1) |
2
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
More news stories
Manipulating genes with hidden TALENs
(PhysOrg.com) -- A better understanding of gene function in model plant and animal systems could be used to develop useful traits in livestock and crop plants, and might someday lead to developments in stem ...
just added |
not rated yet |
0
|
Ordered planar polymers created for the first time
(PhysOrg.com) -- Scientists under the direction of ETH Zurich have created a minor sensation in synthetic chemistry. They succeeded for the first time in producing regularly ordered planar polymers that form ...
1 hour ago |
5 / 5 (2) |
1
|
Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy
For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...
18 hours ago |
4.5 / 5 (19) |
18
|
New method to examine batteries -- MRI from the inside
There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...
Chemistry / Analytical Chemistry
18 hours ago |
5 / 5 (7) |
0
|
Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water
A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...
Feb 09, 2012 |
4.8 / 5 (16) |
21
|
With climate change, today's '100-year floods' may happen every three to 20 years: research
Last August, Hurricane Irene spun through the Caribbean and parts of the eastern United States, leaving widespread wreckage in its wake. The Category 3 storm whipped up water levels, generating storm surges ...
Researchers make better heat sensor based on butterfly wings
(PhysOrg.com) -- Scientists have long known that butterfly wings produce their iridescent colors by bouncing light around and between tiny ridges in structures made of chitin. More recently they’ve discovered ...
The joy of cheques
An electronic cheque which eliminates the need for costly processing by banks but preserves the simplicity and ease of a traditional cheque book has been designed by a team of academics in the UK.
Research shows promise in converting camelina oil into jet fuel
(PhysOrg.com) -- Researchers at Montana State University-Northern have developed a process to convert camelina oil to jet fuel and other high-value chemicals. MSU has applied for a U.S. patent and research is ongoing.
Couples in the same place emotionally stay together, study says
(Medical Xpress) -- Despite lifes ups and downs, couples whose feelings are in sync consistently over time are more likely to stay together, says a University of California, Davis, study.
Researchers make breakthrough in stem cell research
(Medical Xpress) -- University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.
Apr 05, 2008
Rank: not rated yet